Ten days after an FDA panel voted against Genta Inc.'s lead drug candidate, the company laid off nearly half its work force in an effort to conserve cash. (BioWorld Today)

Ten days after an FDA panel voted against Genta Inc.'s lead drug candidate, the company laid off nearly half its work force in an effort to conserve cash. (BioWorld Today)